Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Islet transplantation: where do we stand now?

Boaz Hirshberg1, Kristina I Rother, David M Harlan

  • 1Transplantation and Autoimmunity Branch, NIDDK/NIH/DHHS, Building 10, Room 11-S-219, Bethesda, MD 20892, USA.

Diabetes/Metabolism Research and Reviews
|June 6, 2003
PubMed
Summary

Islet transplantation offers long-term insulin independence for type 1 diabetes, but challenges like donor shortage and drug toxicity remain. Further research is needed to assess its long-term benefits and risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Ninety-Six-Week Results from the Randomized Phase 2/3 PHOTON Trial.

Ophthalmology·2025
Same author

Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial.

Ophthalmology·2025
Same author

The antigen presentation landscape of cytokine-stressed human pancreatic islets.

Cell reports·2025
Same author

Correction to: Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Circulation·2025
Same author

GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial.

Nature communications·2025
Same author

Herpes Simplex Virus 1 Infection of Human Brain Organoids and Pancreatic Stem Cell-Islets Drives Organoid-Specific Transcripts Associated with Alzheimer's Disease and Autoimmune Diseases.

Cells·2024

Area of Science:

  • Endocrinology
  • Transplantation Immunology
  • Metabolic Diseases

Background:

  • Islet transplantation has shown promise for type 1 diabetes, achieving insulin independence in some patients.
  • Despite advancements, significant limitations hinder widespread clinical application.

Purpose of the Study:

  • To evaluate the current status and future potential of islet transplantation for diabetes treatment.
  • To identify key challenges and areas for further research in islet transplantation.

Main Methods:

  • Review of recent clinical outcomes in islet transplantation.
  • Analysis of factors limiting the technique's efficacy and safety.
  • Consideration of long-term patient outcomes and potential complications.

Related Experiment Videos

Main Results:

  • Several centers report successful long-term insulin independence post-transplantation.
  • Major limitations include donor islet scarcity, surgical complications, immunosuppressive drug toxicity, and suboptimal glycemic control.
  • The overall impact on patient survival and diabetes-associated complications requires further investigation.

Conclusions:

  • Islet transplantation is a promising, but not yet universally applicable, treatment for type 1 diabetes.
  • Overcoming donor shortages and improving immunosuppression strategies are critical for broader adoption.
  • Long-term efficacy, safety, and impact on diabetes complications need continued study.